{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-26-000044","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2026-08-06T11:19:04+00:00","discovered_at":"2026-08-06T11:20:00.387184+00:00","generated_at":"2026-08-06T11:20:05.647748+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sotera Health Q2 net income jumps to $54M; raises FY 2026 revenue and EBITDA guidance","bullets":["Q2 net revenues +9.2% (+8.0% constant currency); net income $54M ($0.19 diluted EPS) vs $8M ($0.03) in Q2 2025.","Adjusted EBITDA +10.0% (+8.7% constant currency); Adjusted EPS $0.26, up 30% per diluted share.","Raises FY 2026 outlook: net revenue growth 5.25%-6.75%, Adjusted EBITDA growth 5.75%-7.25% on constant currency basis.","Segment constant currency growth: Sterigenics 7.0%, Nordion 16.7%, Nelson Labs 5.4%; Net leverage ratio 3.0x, liquidity ~$950M."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-26-000044","json":"https://secwatch.observer/filing/0001822479-26-000044.json","markdown":"https://secwatch.observer/filing/0001822479-26-000044.md","text":"https://secwatch.observer/filing/0001822479-26-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/0001822479-26-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/shc-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:20:05.647748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}